These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16551221)

  • 1. Hyperosmolar agents and clearance of mucus in the diseased airway.
    Daviskas E; Anderson SD
    J Aerosol Med; 2006; 19(1):100-9. PubMed ID: 16551221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmotic stimuli increase clearance of mucus in patients with mucociliary dysfunction.
    Daviskas E; Robinson M; Anderson SD; Bye PT
    J Aerosol Med; 2002; 15(3):331-41. PubMed ID: 12396422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoactive agents for chronic, non-cystic fibrosis lung disease: A systematic review and meta-analysis.
    Tarrant BJ; Le Maitre C; Romero L; Steward R; Button BM; Thompson BR; Holland AE
    Respirology; 2017 Aug; 22(6):1084-1092. PubMed ID: 28397992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
    Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E; Anderson SD; Eberl S; Young IH
    Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum.
    Daviskas E; Anderson SD; Gomes K; Briffa P; Cochrane B; Chan HK; Young IH; Rubin BK
    Respirology; 2005 Jan; 10(1):46-56. PubMed ID: 15691238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic agents for mucus clearance in bronchiectasis.
    Nair GB; Ilowite JS
    Clin Chest Med; 2012 Jun; 33(2):363-70. PubMed ID: 22640851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
    Feng W; Garrett H; Speert DP; King M
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):710-4. PubMed ID: 9517580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?
    Bilton D; Stanford G
    Curr Opin Pulm Med; 2014 Nov; 20(6):601-6. PubMed ID: 25221855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasis.
    Daviskas E; Anderson SD; Young IH
    Respir Med; 2010 Mar; 104(3):371-7. PubMed ID: 19914814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P; Greenstone M
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002996. PubMed ID: 16625566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway clearance strategies in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Main E; Grillo L; Rand S
    Semin Respir Crit Care Med; 2015 Apr; 36(2):251-66. PubMed ID: 25826592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of action of hypertonic saline on mucociliary clearance in the normal lung.
    Bennett WD; Wu J; Fuller F; Balcazar JR; Zeman KL; Duckworth H; Donn KH; O'Riordan TG; Boucher RC; Donaldson SH
    J Appl Physiol (1985); 2015 Jun; 118(12):1483-90. PubMed ID: 25911685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasis.
    Daviskas E; Anderson SD; Eberl S; Young IH
    Eur Respir J; 2008 Apr; 31(4):765-72. PubMed ID: 18057051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic aerosols and airway secretions.
    Rubin BK
    J Aerosol Med; 1996; 9(1):123-30. PubMed ID: 10160202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P; Greenstone M
    Cochrane Database Syst Rev; 2001; (2):CD002996. PubMed ID: 11406058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled hyperosmolar agents for bronchiectasis.
    Wills P; Greenstone M
    Cochrane Database Syst Rev; 2002; (1):CD002996. PubMed ID: 11869647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.